BC
Birchview Capital’s Vanda Pharmaceuticals VNDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Hold |
0
| – | – | – | 64 |
|
2022
Q2 | – | Sell |
-50,000
| Closed | -$566K | – | 64 |
|
2022
Q1 | $566K | Sell |
50,000
-10,000
| -17% | -$113K | 0.41% | 40 |
|
2021
Q4 | $941K | Sell |
60,000
-20,000
| -25% | -$314K | 0.61% | 31 |
|
2021
Q3 | $1.37M | Hold |
80,000
| – | – | 0.93% | 21 |
|
2021
Q2 | $1.72M | Hold |
80,000
| – | – | 1.03% | 16 |
|
2021
Q1 | $1.2M | Hold |
80,000
| – | – | 0.71% | 23 |
|
2020
Q4 | $1.05M | Hold |
80,000
| – | – | 0.61% | 28 |
|
2020
Q3 | $773K | Hold |
80,000
| – | – | 0.52% | 26 |
|
2020
Q2 | $915K | Hold |
80,000
| – | – | 0.55% | 26 |
|
2020
Q1 | $829K | Hold |
80,000
| – | – | 0.74% | 19 |
|
2019
Q4 | $1.31M | Hold |
80,000
| – | – | 0.95% | 14 |
|
2019
Q3 | $1.06M | Hold |
80,000
| – | – | 0.71% | 12 |
|
2019
Q2 | $1.13M | Hold |
80,000
| – | – | 0.69% | 18 |
|
2019
Q1 | $1.47M | Hold |
80,000
| – | – | 0.92% | 9 |
|
2018
Q4 | $2.09M | Sell |
80,000
-8,000
| -9% | -$209K | 1.98% | 8 |
|
2018
Q3 | $2.02M | Hold |
88,000
| – | – | 1.3% | 5 |
|
2018
Q2 | $1.68M | Hold |
88,000
| – | – | 1.14% | 11 |
|
2018
Q1 | $1.48M | Hold |
88,000
| – | – | 0.98% | 10 |
|
2017
Q4 | $1.34M | Buy |
88,000
+20,000
| +29% | +$304K | 0.78% | 11 |
|
2017
Q3 | $1.22M | Hold |
68,000
| – | – | 0.63% | 12 |
|
2017
Q2 | $1.11M | Buy |
68,000
+14,000
| +26% | +$228K | 0.59% | 10 |
|
2017
Q1 | $756K | Buy |
54,000
+32,000
| +145% | +$448K | 0.42% | 18 |
|
2016
Q4 | $351K | Buy |
+22,000
| New | +$351K | 0.22% | 24 |
|